The impact of different censoring methods for analyzing survival using real-world data with linked mortality information: a simulation study

Author:

Hsu Wei-Chun1,Crowley Aaron1,Parzynski Craig S.1

Affiliation:

1. Genesis Research Group

Abstract

Abstract Background Evaluating outcome reliability is critical in real-world evidence studies. Overall survival is a common clinical outcome in these studies; however, its capture in real-world data sources is incomplete and often supplemented with linked mortality information from external sources. There are conflicting recommendations for censoring overall survival in real-world evidence studies. We conducted a simulation study to understand the impact of these different methods on estimating median survival and log hazard ratios when external mortality information is not fully captured. Methods We used Monte Carlo simulation to emulate a non-randomized comparative effectiveness study of two treatments with real-world data from electronic health records and linked external mortality data. We simulated the time to death, the time to last database activity and the time to data cutoff. We attributed death events after the last database activity to linked external mortality data and randomly set them to missing to reflect the sensitivity and specificity of contemporary real-world data sources. Two censoring schemes were evaluated: (1) censor at the last activity date without an observed death, and (2) censor at the end of data availability (data cutoff). We used bias, coverage, and rejection rate to assess the performance of each method in estimating median survival and log hazard ratios under varying amounts of incomplete mortality information and varying treatment effects, length of follow-up, and sample size. Results When mortality information was captured, median survival estimates were unbiased when censoring at data cutoff and underestimated when censoring at the last activity. When linked mortality information was missing, censoring at the last activity date underestimated the median survival, while censoring at the data cutoff overestimated it. As missing linked mortality information increased, bias decreased when censoring at the last activity date and increased when censoring at data-off. Conclusions Researchers should understand the completeness of linked external mortality information when choosing how to censor the analysis of overall survival using real-world data. Substantial bias in median survival estimates can occur if an inappropriate censoring scheme is selected. We advocate for real-world data providers to perform validation studies of their mortality data and to publish their findings to inform methodological decisions better.

Publisher

Research Square Platform LLC

Reference28 articles.

1. Public Law 114–255: 21st Century Cures Act., (2016).

2. FDA. Considerations for the Use of Real-World Data and RealWorld Evidence to Support Regulatory Decision-Making for Drug and Biological Products 2021 [Available from: https://www.fda.gov/media/154714/download.

3. Real-World FDA. Data: Assessing Registries to Support Regulatory Decision-Making for Drug and Biological Products Guidance for Industry 2021 [Available from: https://www.fda.gov/media/154449/download.

4. FDA. Real-World Data. : Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision Making for Drug and Biological Products 2021 [Available from: https://www.fda.gov/media/152503/download.

5. FDA. Data Standards for Drug and Biological Product Submissions Containing Real-World Data 2021 [Available from: https://www.fda.gov/media/153341/download.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3